Operating Expenses Cambiamento Data
Adma Biologics USD 85.84M 27.26M 2023-12
AstraZeneca USD 9.54B 578M 2023-09
BioCryst Pharmaceuticals USD 98.66M 33.55M 2023-09
Cassava Sciences USD 27.88M 898K 2023-09
Dynavax Technologies USD 64.09M 311K 2023-12
Geron USD 54.31M 6.54M 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
MannKind USD 50.61M 4.46M 2023-12
Merck USD 16.56B 6.35B 2023-12
Minerva Neurosciences USD 6.08M 1.56M 2023-09
Moderna USD 2.8B 1.04B 2023-12
Novavax USD 312.62M 56.35M 2023-09
Peregrine Pharmaceuticals USD 36.62M 3.27M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
TG Therapeutics USD 56.46M 5.42M 2023-12



Novavax Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.